Ask AI
Individualized obesity care TM

CE / CME

Enhancing Outcomes in Obesity Care With Incretin-Based Therapy and Individualized Treatment Plans

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

ABIM MOC: maximum of 0.50 Medical Knowledge MOC point

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Nurse Practitioners/Nurses: 0.50 Nursing contact hour

Released: July 15, 2026

Expiration: July 14, 2027

Activity

Progress
1 2 3
Course Completed

Introduction

In this module, Nicholas Pennings, DO, discusses the rationale for integrating incretin-based therapies in obesity care and shares his strategies for individualizing treatment to enhance patient outcomes. Key points are illustrated through a detailed patient case to support your continued learning and daily practice.

The key points discussed in this module are illustrated with thumbnails from the accompanying downloadable PowerPoint slideset, which can be downloaded by clicking on any of the slide thumbnails in the module alongside the expert commentary.

Before continuing with this educational activity, please take a moment to answer the following questions.

How many people with obesity do you provide care for in a typical week?

For those who practice in academic or community settings, please indicate your practice setting:

A 52-year-old woman with obesity, body mass index (BMI) 35 kg/m², hypertension, hypothyroidism, prediabetes, dyslipidemia, and knee pain limiting walking asks about “the new weight-loss pills.” She works rotating hospital shifts, takes morning medications, wants to avoid injections, and is worried about nausea and cost.

Which plan best applies shared decision-making to obesity pharmacotherapy?